Revenue Cycle Management Market - Global Forecast To 2030
商品番号 : SMB-7309
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年7月 |
| ページ数 | 382 |
| 図表数 | 487 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、既存企業だけでなく新規参入企業や小規模企業にとっても、市場の動向を把握し、シェア拡大に繋げる上で役立ちます。本レポートをご購入いただいた企業は、以下の5つの戦略のいずれか、または組み合わせて活用することができます。
The global revenue cycle management market is projected to reach USD 105.35 billion by 2030 from USD 61.11 billion in 2025, at a CAGR of 11.5% during the forecast period. The RCM market continues to be heavily influenced by evolving coding regulations and classification standards. For instance, CMS implemented major FY 2025 ICD-10 updates, including 395 new codes, 252 deletions, and 13 revisions, effective October 1, 2024, across diagnoses and procedures. These frequent, large-scale updates are driving greater reliance on automated RCM platforms to manage coding complexity and maintain billing accuracy. However, a significant challenge persists in emerging regions, where there is a considerable shortage of trained HCIT personnel and financial limitations on upgrading legacy systems. This gap in skills and infrastructure may hinder the deployment of RCM solutions, which could slightly temper overall market growth.
世界の収益サイクル管理市場は、2025年の611億1,000万米ドルから2030年には1,053億5,000万米ドルに達し、予測期間中に11.5%の年平均成長率（CAGR）で成長すると予測されています。RCM市場は、進化するコーディング規制と分類基準の影響を強く受け続けています。例えば、CMS（医療サービス管理局）は、2024年10月1日に発効する2025年度ICD-10の主要なアップデートを実施し、診断と処置全体にわたって395の新しいコード、252の削除、13の改訂を実施しました。これらの頻繁で大規模なアップデートにより、コーディングの複雑さを管理し、請求の正確性を維持するために、自動化されたRCMプラットフォームへの依存が高まっています。しかし、新興地域では、訓練を受けたHCIT人材が大幅に不足し、レガシーシステムのアップグレードに資金的な制約があるなど、依然として大きな課題が残っています。このスキルとインフラのギャップは、RCMソリューションの導入を妨げ、市場全体の成長を若干抑制する可能性があります。
“The outsourcing services segment is expected to be the fastest-growing segment in the revenue cycle management market during the forecast period.”
Based on offering, the revenue cycle management market has been divided into product offerings and outsourcing services. Outsourcing services commanded the larger share of the revenue cycle management market in 2024. This segment’s significant market share and rapid growth are primarily due to the demand for IT infrastructure and the shortage of skilled healthcare IT personnel. Additionally, the increasing volume of medical billing audits and compliance reporting has made it challenging for in-house teams to keep up, leading many providers to partner with specialized vendors. Outsourcing also assists healthcare organizations in managing seasonal fluctuations in billing volumes, such as during open enrollment or flu season. Moreover, service providers are now increasingly offering bundled revenue cycle management solutions that integrate coding, accounts receivable management, and analytics. This approach reduces operational fragmentation and provides comprehensive visibility into revenue processes.
“The back-end revenue cycle segment is estimated to hold the largest share of the revenue cycle management market in 2024.”
Based on product, the revenue cycle management market is segmented into patient access solutions, mid-revenue cycle solutions, and back-end revenue cycle solutions. The back-end revenue cycle solutions segment is expected to hold the largest share in 2024 due to the growing complexity of payer reimbursement models and the increasing volume of denied claims requiring advanced resolution strategies. The increased use of automation in collections, payment posting, and appeals processing has led to greater adoption in this area. Furthermore, the incorporation of predictive analytics into accounts receivable management allows providers to prioritize high-risk accounts and expedite revenue generation.
“The Asia Pacific region is expected to register the highest growth rate in the revenue cycle management market during the forecast period.”
The global revenue cycle management market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific is expected to register the highest growth during the forecast period. Several factors are driving the growth of revenue cycle management (RCM) systems in healthcare. The rapid digital transformation of hospital billing systems and increasing investments by private healthcare providers in cloud-based RCM tools are significant contributors. Additionally, government-led healthcare digitization programs, such as India’s Ayushman Bharat Digital Mission, are promoting the adoption of RCM platforms. Furthermore, the emergence of regional RCM outsourcing hubs in countries like the Philippines and Malaysia also fuels market expansion.
The breakdown of primary participants is as mentioned below:
- By Company Type: Tier 1 (41%), Tier 2 (31%), and Tier 3 (28%)
- By Designation: C-level Executives (44%), Directors (31%), and Others (25%)
- By Region: North America (45%), Europe (28%), Asia Pacific (20%), Latin America (4%), and the Middle East & Africa (3%)
Key Players
The prominent players in this market are Optum, Inc. (US), R1 RCM Inc. (US), Oracle (US), Medical Information Technology, Inc. (US), McKesson Corporation (US), Solventum (US), Experian Information Solutions, Inc. (Ireland), Conifer Health Solutions. (US), Veradigm LLC (US), eClinicalWorks (US), Cognizant (US), athenahealth, Inc. (US), The SSI Group, LLC (US), Huron Consulting Group Inc. (US), AdvancedMD, Inc. (US), GeBBS (US), Epic Systems Corporation (US), TruBridge (US), CareCloud, Inc. (US), MEDHOST (US), AdvantEdge Healthcare Solutions (US), FinThrive (US), Plutus Health (US), Omega Healthcare Management Services (India), and Vee Healthtek, Inc. (US). Players adopted organic as well as inorganic growth strategies such as product launches and enhancements, investments, partnerships, collaborations, joint ventures, funding, acquisitions, expansions, agreements, contracts, and alliances to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.
Research Coverage
- The report studies the revenue cycle management market based on offering, solution type, delivery mode, end user, and region.
- The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
- The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
- The report studies micromarkets with respect to their growth trends, prospects, and contributions to the total revenue cycle management market.
- The report forecasts the revenue of market segments with respect to five major regions.
Reasons to Buy the Report
The report can help established firms, as well as new entrants/smaller firms, gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the five strategies mentioned below.
This report provides insights into the following pointers:
Analysis of key drivers (growing regulatory requirements and government initiatives, increasing patient volume and subsequent growth in health insurance, loss of revenue due to billing errors and declining reimbursements, growing need to manage unstructured healthcare data, and rising demand for robust process improvements in the healthcare sector), restraints (high deployment costs and IT infrastructural constraints in emerging economies), opportunities (increasing outsourcing services in emerging economies and growing demand for AI and cloud-based deployment), and challenges (issues related to data security and confidentiality and reluctance to switch from conventional methods) influencing the growth of the revenue cycle management market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the revenue cycle management market.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of revenue cycle management solutions across regions.
- Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the revenue cycle management market.
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the revenue cycle management market.
Table of Contents
1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.3 STUDY SCOPE 36
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 36
1.3.2 INCLUSIONS & EXCLUSIONS 37
1.3.3 YEARS CONSIDERED 38
1.4 CURRENCY CONSIDERED 39
1.5 KEY STAKEHOLDERS 39
1.6 LIMITATIONS 39
1.7 SUMMARY OF CHANGES 40
2 RESEARCH METHODOLOGY 41
2.1 RESEARCH DATA 41
2.1.1 SECONDARY DATA 42
2.1.1.1 Key data from secondary sources 42
2.1.2 PRIMARY DATA 43
2.1.2.1 Key data from primary sources 44
2.1.2.2 Insights from primary experts 44
2.2 MARKET SIZE ESTIMATION: REVENUE CYCLE MANAGEMENT MARKET 45
2.2.1 TOP-DOWN APPROACH 49
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 50
2.4 MARKET RANKING ANALYSIS 51
2.5 RESEARCH ASSUMPTIONS 51
2.6 RISK ASSESSMENT 51
2.7 RESEARCH LIMITATIONS 52
2.7.1 METHODOLOGY-RELATED LIMITATIONS 52
2.7.2 SCOPE-RELATED LIMITATIONS 52
3 EXECUTIVE SUMMARY 53
4 PREMIUM INSIGHTS 58
4.1 OPPORTUNITIES IN REVENUE CYCLE MANAGEMENT MARKET 58
4.2 REVENUE CYCLE MANAGEMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 59
4.3 REVENUE CYCLE MANAGEMENT MARKET: REGIONAL MIX (2023–2030) 60
4.4 REVENUE CYCLE MANAGEMENT MARKET: DEVELOPED VS. EMERGING ECONOMIES, 2025 VS. 2030 61
5 MARKET OVERVIEW 62
5.1 INTRODUCTION 62
5.2 MARKET DYNAMICS 62
5.2.1 DRIVERS 63
5.2.1.1 Growing regulatory requirements and government initiatives 63
5.2.1.2 Increasing patient volume and subsequent growth in health insurance 64
5.2.1.3 Loss of revenue due to billing errors and declining reimbursements 65
5.2.1.4 Growing need to manage unstructured healthcare data 65
5.2.1.5 Rising demand for robust process improvements in healthcare sector 66
5.2.2 RESTRAINTS 66
5.2.2.1 High deployment costs 66
5.2.2.2 IT infrastructural constraints in emerging economies 67
5.2.3 OPPORTUNITIES 67
5.2.3.1 Increasing outsourcing services in emerging economies 67
5.2.3.2 Growing demand for AI and cloud-based deployment 68
5.2.4 CHALLENGES 69
5.2.4.1 Issues related to data security and confidentiality 69
5.2.4.2 Reluctance to switch from conventional methods 72
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73
5.4 INDUSTRY TRENDS 73
5.4.1 GREATER FOCUS ON PATIENT FINANCIAL EXPERIENCE 73
5.4.2 USE OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING 74
5.4.3 PIVOTAL ROLE OF DATA ANALYSIS IN MANAGING HEALTHCARE
REVENUE CYCLES 74
5.4.4 INCREASING NUMBER OF PARTNERSHIPS AND COLLABORATIONS
TO DRIVE INNOVATION 74
5.5 TECHNOLOGY ANALYSIS 75
5.5.1 KEY TECHNOLOGIES 75
5.5.1.1 AI platforms 75
5.5.1.2 Cloud computing 75
5.5.2 COMPLEMENTARY TECHNOLOGIES 76
5.5.2.1 Electronic health records (EHRs) 76
5.5.2.2 Telehealth platforms 76
5.6 ECOSYSTEM ANALYSIS 76
5.7 VALUE CHAIN ANALYSIS 79
5.8 PORTER’S FIVE FORCES ANALYSIS 80
5.8.1 INTENSITY OF COMPETITIVE RIVALRY 81
5.8.2 BARGAINING POWER OF SUPPLIERS 81
5.8.3 BARGAINING POWER OF BUYERS 81
5.8.4 THREAT OF NEW ENTRANTS 81
5.8.5 THREAT OF SUBSTITUTES 81
5.9 REGULATORY ANALYSIS 82
5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND
OTHER ORGANIZATIONS 82
5.9.2 REGULATORY LANDSCAPE 85
5.10 PATENT ANALYSIS 85
5.10.1 PATENT PUBLICATION TRENDS FOR REVENUE CYCLE MANAGEMENT MARKET 85
5.10.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR
REVENUE CYCLE MANAGEMENT 86
5.10.3 MAJOR PATENTS IN REVENUE CYCLE MANAGEMENT MARKET 87
5.11 CASE STUDY ANALYSIS 89
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 90
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 90
5.12.2 BUYING CRITERIA 91
5.13 KEY CONFERENCES & EVENTS IN 2025–2026 92
5.14 PRICING ANALYSIS 93
5.15 IMPACT OF 2025 US TARIFFS ON REVENUE CYCLE MANAGEMENT MARKET 93
5.15.1 KEY TARIFF RATES 94
5.15.2 PRICE IMPACT ANALYSIS 95
5.15.3 IMPACT ON COUNTRY/REGION 95
5.15.3.1 US 95
5.15.3.2 Europe 96
5.15.3.3 APAC 97
5.15.4 IMPACT ON END-USE INDUSTRIES 98
6 REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE 100
6.1 INTRODUCTION 101
6.2 END-TO-END SOLUTIONS 101
6.2.1 ABILITY OF INTEGRATED RCM PLATFORMS TO DRIVE OPERATIONAL EFFICIENCY AND FINANCIAL PERFORMANCE TO BOOST ADOPTION 101
6.3 NICHE/POINT SOLUTIONS 102
6.3.1 SPECIALIZED RCM TOOLS TO GAIN MOMENTUM AMID DEMAND
FOR TARGETED, HIGH-ROI SOLUTIONS 102
7 REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING 104
7.1 INTRODUCTION 105
7.2 PRODUCTS 105
7.2.1 PATIENT ACCESS SOLUTIONS 107
7.2.1.1 Eligibility verification solutions 108
7.2.1.1.1 Eligibility verification solutions segment to account for largest share of patient access solutions market 108
7.2.1.2 Pre-certification & authorization solutions 109
7.2.1.2.1 Ability of electronic pre-certification and authorization solutions to help reduce error risks to drive growth 109
7.2.1.3 Other patient access solutions 110
7.2.2 MID-REVENUE CYCLE SOLUTIONS 111
7.2.2.1 Clinical coding solutions 113
7.2.2.1.1 Increasing complexity of medical codes to drive market 113
7.2.2.2 Clinical documentation improvement solutions 114
7.2.2.2.1 Automated feedback and guidance by CDI solutions to help physicians improve accuracy of patient records 114
7.2.2.3 Other mid-revenue cycle solutions 115
7.2.3 BACK-END REVENUE CYCLE SOLUTIONS 115
7.2.3.1 Claims processing solutions 117
7.2.3.1.1 Ability of claims processing solutions to help reduce false claims and manual effort to boost demand 117
7.2.3.2 Denial management solutions 118
7.2.3.2.1 Ability to help healthcare payers and providers with effective claims management to drive market 118
7.2.3.3 Other back-end revenue cycle solutions 119
7.3 OUTSOURCING SERVICES 120
7.3.1 PATIENT ACCESS OUTSOURCING SERVICES 121
7.3.1.1 Patient access outsourcing services segment to account for largest share of outsourcing services market 121
7.3.2 MID-REVENUE CYCLE OUTSOURCING SERVICES 122
7.3.2.1 Increasing losses due to billing errors, scarcity of IT professionals, and infrastructure limitations to drive market 122
7.3.3 BACK-END REVENUE CYCLE OUTSOURCING SERVICES 123
7.3.3.1 Shortage of skilled HCIT professionals to drive market 123
8 REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE 125
8.1 INTRODUCTION 126
8.2 ON-PREMISE SOLUTIONS 126
8.2.1 ABILITY TO REUSE EXISTING SERVERS AND STORAGE HARDWARE
TO DRIVE DEMAND FOR ON-PREMISE SOLUTIONS 126
8.3 CLOUD-BASED SOLUTIONS 127
8.3.1 DEMAND FOR AFFORDABLE CLOUD-BASED SOLUTIONS FROM SMALL
AND MEDIUM-SIZED HEALTHCARE FACILITIES TO DRIVE MARKET 127
9 REVENUE CYCLE MANAGEMENT MARKET, BY END USER 129
9.1 INTRODUCTION 130
9.2 HEALTHCARE PROVIDERS 130
9.2.1 INPATIENT FACILITIES 131
9.2.1.1 Hospitals 133
9.2.1.1.1 Growing need to improve profitability in healthcare operations to drive adoption of RCM tools in hospitals 133
9.2.1.2 Other inpatient facilities 133
9.2.2 OUTPATIENT FACILITIES 134
9.2.2.1 Physicians’ practices 136
9.2.2.1.1 High demand for integration of EHR with practice management systems to support market growth 136
9.2.2.2 Ambulatory surgical centers (ASCs) 136
9.2.2.2.1 Eroding patient volumes at hospitals due to high infection rate of COVID-19 to drive demand for ASCs 136
9.2.2.3 Hospital outpatient facilities 137
9.2.2.3.1 Need to maintain documentation for high volume of patients in hospital OPDs to drive demand for RCM solutions 137
9.2.2.4 Diagnostic & imaging centers 138
9.2.2.4.1 Growing preference for technologically advanced specialty clinics to drive demand 138
9.2.2.5 Other outpatient facilities 139
9.3 HEALTHCARE PAYERS 140
9.3.1 INCREASING PRODUCTIVITY AND PROFITABILITY OF CODING OPERATIONS TO DRIVE ADOPTION OF RCM SOLUTIONS 140
10 REVENUE CYCLE MANAGEMENT MARKET, BY REGION 142
10.1 INTRODUCTION 143
10.2 NORTH AMERICA 144
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 144
10.2.2 US 151
10.2.2.1 Growing focus of healthcare providers on improving care quality and reducing medical errors to drive market 151
10.2.3 CANADA 157
10.2.3.1 Need for healthcare cost containment and financial management of healthcare organizations to support market growth 157
10.3 EUROPE 163
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 164
10.3.2 GERMANY 169
10.3.2.1 Increasing patient volume to boost adoption of RCM solutions 169
10.3.3 FRANCE 175
10.3.3.1 Government investments to increase demand for effective RCM solutions 175
10.3.4 UK 181
10.3.4.1 Growing patient pool to boost demand for RCM solutions & services 181
10.3.5 ITALY 187
10.3.5.1 Initiatives toward digitalizing patient records to drive market 187
10.3.6 SPAIN 193
10.3.6.1 IT infrastructural improvements to boost market 193
10.3.7 REST OF EUROPE 199
10.4 ASIA PACIFIC 204
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 205
10.4.2 JAPAN 212
10.4.2.1 Government mandates to boost adoption of RCM solutions 212
10.4.3 CHINA 218
10.4.3.1 Digitalization and improving infrastructure to support market growth 218
10.4.4 INDIA 224
10.4.4.1 Growing patient pool to support market growth 224
10.4.5 REST OF ASIA PACIFIC 230
10.5 LATIN AMERICA 235
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 236
10.5.2 BRAZIL 241
10.5.2.1 Brazil to dominate revenue cycle management market in Latin America 241
10.5.3 MEXICO 247
10.5.3.1 Increase in focus of digital health to boost market growth 247
10.5.4 REST OF LATIN AMERICA 252
10.6 MIDDLE EAST & AFRICA 257
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 258
10.6.2 GCC COUNTRIES 264
10.6.2.1 Rising healthcare investments to fuel uptake 264
10.6.3 REST OF MIDDLE EAST & AFRICA 269
11 COMPETITIVE LANDSCAPE 276
11.1 OVERVIEW 276
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 276
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN REVENUE CYCLE MANAGEMENT MARKET 276
11.3 REVENUE ANALYSIS, 2020–2024 278
11.4 MARKET SHARE ANALYSIS, 2024 279
11.5 MARKET RANKING ANALYSIS 282
11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 283
11.6.1 STARS 284
11.6.2 EMERGING LEADERS 284
11.6.3 PERVASIVE PLAYERS 284
11.6.4 PARTICIPANTS 284
11.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 286
11.6.5.1 Company footprint 286
11.6.5.2 Region footprint 287
11.6.5.3 Solution type footprint 288
11.6.5.4 Offering footprint 289
11.6.5.5 End-user footprint 290
11.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 291
11.7.1 PROGRESSIVE COMPANIES 291
11.7.2 RESPONSIVE COMPANIES 291
11.7.3 DYNAMIC COMPANIES 291
11.7.4 STARTING BLOCKS 291
11.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 293
11.7.5.1 Detailed list of key startups/SMEs 293
11.7.5.2 Competitive benchmarking of startups/SMEs 293
11.8 COMPANY VALUATION & FINANCIAL METRICS 294
11.8.1 COMPANY VALUATION 294
11.8.2 FINANCIAL METRICS 294
11.9 BRAND/SOFTWARE COMPARISON 295
11.10 COMPETITIVE SCENARIO 296
11.10.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 296
11.10.2 DEALS 297
11.10.3 EXPANSIONS 297
11.10.4 OTHER DEVELOPMENTS 298
12 COMPANY PROFILES 299
12.1 KEY PLAYERS 299
12.1.1 OPTUM, INC. 299
12.1.1.1 Business overview 299
12.1.1.2 Products & services offered 300
12.1.1.3 Recent developments 301
12.1.1.3.1 Product/Service launches 301
12.1.1.3.2 Deals 301
12.1.1.4 MnM view 302
12.1.1.4.1 Right to win 302
12.1.1.4.2 Strategic choices 302
12.1.1.4.3 Weaknesses & competitive threats 303
12.1.2 ORACLE 304
12.1.2.1 Business overview 304
12.1.2.2 Products & services offered 305
12.1.2.3 Recent developments 307
12.1.2.3.1 Product/Service launches & upgrades 307
12.1.2.3.2 Deals 308
12.1.2.4 MnM view 309
12.1.2.4.1 Right to win 309
12.1.2.4.2 Strategic choices 309
12.1.2.4.3 Weaknesses & competitive threats 309
12.1.3 MCKESSON CORPORATION 310
12.1.3.1 Business overview 310
12.1.3.2 Products & services offered 311
12.1.3.3 Recent developments 312
12.1.3.3.1 Deals 312
12.1.3.4 MnM view 312
12.1.3.4.1 Right to win 312
12.1.3.4.2 Strategic choices 312
12.1.3.4.3 Weaknesses & competitive threats 313
12.1.4 EPIC SYSTEMS CORPORATION 314
12.1.4.1 Business overview 314
12.1.4.2 Products & services offered 314
12.1.4.3 Recent developments 315
12.1.4.3.1 Product/Service launches & upgrades 315
12.1.4.3.2 Deals 315
12.1.4.4 MnM view 316
12.1.4.4.1 Right to win 316
12.1.4.4.2 Strategic choices 316
12.1.4.4.3 Weaknesses & competitive threats 316
12.1.5 SOLVENTUM 317
12.1.5.1 Business overview 317
12.1.5.2 Products & services offered 319
12.1.5.3 Recent developments 319
12.1.5.3.1 Deals 319
12.1.5.4 MnM view 320
12.1.5.4.1 Right to win 320
12.1.5.4.2 Strategic choices 320
12.1.5.4.3 Weaknesses & competitive threats 320
12.1.6 R1 RCM INC. 321
12.1.6.1 Business overview 321
12.1.6.2 Products & services offered 321
12.1.6.3 Recent developments 323
12.1.6.3.1 Product/Service launches 323
12.1.6.3.2 Deals 324
12.1.6.3.3 Other developments 325
12.1.7 EXPERIAN INFORMATION SOLUTIONS, INC. 326
12.1.7.1 Business overview 326
12.1.7.2 Products & services offered 327
12.1.7.3 Recent developments 329
12.1.7.3.1 Product/Service launches 329
12.1.7.3.2 Deals 329
12.1.8 CONIFER HEALTH SOLUTIONS 330
12.1.8.1 Business overview 330
12.1.8.2 Products & services offered 330
12.1.8.3 Recent developments 331
12.1.8.3.1 Deals 331
12.1.9 VERADIGM LLC 332
12.1.9.1 Business overview 332
12.1.9.2 Products & services offered 333
12.1.9.3 Recent developments 334
12.1.9.3.1 Product/Service launches 334
12.1.9.3.2 Deals 335
12.1.10 ECLINICALWORKS 336
12.1.10.1 Business overview 336
12.1.10.2 Products & services offered 336
12.1.10.3 Recent developments 337
12.1.10.3.1 Deals 337
12.1.11 COGNIZANT 338
12.1.11.1 Business overview 338
12.1.11.2 Products & services offered 339
12.1.11.3 Recent developments 340
12.1.11.3.1 Product/Service launches 340
12.1.11.3.2 Deals 341
12.1.12 ATHENAHEALTH, INC. 342
12.1.12.1 Business overview 342
12.1.12.2 Products & services offered 342
12.1.12.3 Recent developments 343
12.1.12.3.1 Product/Service launches & approvals 343
12.1.12.3.2 Deals 344
12.1.12.3.3 Other developments 345
12.1.13 THE SSI GROUP, LLC 346
12.1.13.1 Business overview 346
12.1.13.2 Products & services offered 346
12.1.13.3 Recent developments 347
12.1.13.3.1 Product/Service launches 347
12.1.14 HURON CONSULTING GROUP INC. 348
12.1.14.1 Business overview 348
12.1.14.2 Products & services offered 349
12.1.15 ADVANCEDMD, INC. 350
12.1.15.1 Business overview 350
12.1.15.2 Products & services offered 350
12.1.15.3 Recent developments 351
12.1.15.3.1 Product/Service upgrades 351
12.1.15.3.2 Deals 352
12.1.16 GEBBS 353
12.1.16.1 Business overview 353
12.1.16.2 Products & services offered 353
12.1.16.3 Recent developments 354
12.1.16.3.1 Deals 354
12.1.17 TRUBRIDGE 356
12.1.17.1 Business overview 356
12.1.17.2 Products & services offered 357
12.1.17.3 Recent developments 358
12.1.17.3.1 Deals 358
12.1.18 CARECLOUD, INC. 359
12.1.18.1 Business overview 359
12.1.18.2 Products & services offered 360
12.1.18.3 Recent developments 361
12.1.18.3.1 Deals 361
12.1.19 MEDICAL INFORMATION TECHNOLOGY, INC. 362
12.1.19.1 Business overview 362
12.1.19.2 Products & services offered 362
12.1.19.3 Recent developments 363
12.1.19.3.1 Deals 363
12.1.20 MEDHOST 364
12.1.20.1 Business overview 364
12.1.20.2 Products & services offered 364
12.1.20.3 Recent developments 365
12.1.20.3.1 Product launches 365
12.1.20.3.2 Deals 366
12.1.20.3.3 Expansions 366
12.2 OTHER PLAYERS 367
12.2.1 ADVANTEDGE HEALTHCARE SOLUTIONS (HEALTH PRIME INTERNATIONAL) 367
12.2.2 FINTHRIVE 368
12.2.3 PLUTUS HEALTH 369
12.2.4 OMEGA HEALTHCARE MANAGEMENT SERVICES 370
12.2.5 VEE HEALTHTEK, INC. 371
13 APPENDIX 373
13.1 DISCUSSION GUIDE 373
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 378
13.3 CUSTOMIZATION OPTIONS 380
13.4 RELATED REPORTS: 380
13.5 AUTHOR DETAILS 381
LIST OF TABLES
TABLE 1 RISK ASSESSMENT: REVENUE CYCLE MANAGEMENT MARKET 51
TABLE 2 REVENUE CYCLE MANAGEMENT MARKET: IMPACT ANALYSIS 63
TABLE 3 TOP 30 HEALTHCARE DATA BREACHES IN US (2011–2024) 71
TABLE 4 REVENUE CYCLE MANAGEMENT MARKET: ROLE IN ECOSYSTEM 78
TABLE 5 REVENUE CYCLE MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 80
TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 82
TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 83
TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 83
TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 84
TABLE 10 REVENUE CYCLE MANAGEMENT MARKET: REGULATORY STANDARDS 85
TABLE 11 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR
REVENUE CYCLE MANAGEMENT 86
TABLE 12 REVENUE CYCLE MANAGEMENT MARKET: LIST OF PATENTS/PATENT APPLICATIONS 88
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 91
TABLE 14 KEY BUYING CRITERIA FOR REVENUE CYCLE MANAGEMENT COMPONENTS 91
TABLE 15 REVENUE CYCLE MANAGEMENT MARKET: DETAILED LIST OF
CONFERENCES & EVENTS 92
TABLE 16 US-ADJUSTED RECIPROCAL TARIFF RATES 94
TABLE 17 REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE,
2023–2030 (USD MILLION) 101
TABLE 18 REVENUE CYCLE MANAGEMENT MARKET FOR END-TO-END SOLUTIONS,
BY REGION, 2023–2030 (USD MILLION) 102
TABLE 19 REVENUE CYCLE MANAGEMENT MARKET FOR NICHE/POINT SOLUTIONS,
BY REGION, 2023–2030 (USD MILLION) 103
TABLE 20 REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 105
TABLE 21 PRODUCTS OFFERED BY KEY MARKET PLAYERS 106
TABLE 22 REVENUE CYCLE MANAGEMENT PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 106
TABLE 23 PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 107
TABLE 24 PATIENT ACCESS SOLUTIONS MARKET, BY REGION, 2023–2030 (USD MILLION) 107
TABLE 25 ELIGIBILITY VERIFICATION SOLUTIONS OFFERED BY KEY MARKET PLAYERS 108
TABLE 26 ELIGIBILITY VERIFICATION SOLUTIONS MARKET, BY REGION,
2023–2030 (USD MILLION) 109
TABLE 27 PRE-CERTIFICATION & AUTHORIZATION SOLUTIONS OFFERED
BY KEY MARKET PLAYERS 110
TABLE 28 PRE-CERTIFICATION & AUTHORIZATION SOLUTIONS MARKET, BY REGION,
2023–2030 (USD MILLION) 110
TABLE 29 OTHER PATIENT ACCESS SOLUTIONS OFFERED BY KEY MARKET PLAYERS 111
TABLE 30 OTHER PATIENT ACCESS SOLUTIONS MARKET, BY REGION,
2023–2030 (USD MILLION) 111
TABLE 31 MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 112
TABLE 32 MID-REVENUE CYCLE SOLUTIONS MARKET, BY REGION,
2023–2030 (USD MILLION) 112
TABLE 33 CLINICAL CODING SOLUTIONS OFFERED BY KEY MARKET PLAYERS 113
TABLE 34 CLINICAL CODING SOLUTIONS MARKET, BY REGION, 2023–2030 (USD MILLION) 113
TABLE 35 CLINICAL DOCUMENTATION IMPROVEMENT SOLUTIONS OFFERED
BY KEY MARKET PLAYERS 114
TABLE 36 CLINICAL DOCUMENTATION IMPROVEMENT SOLUTIONS MARKET,
BY REGION, 2023–2030 (USD MILLION) 114
TABLE 37 OTHER MID-REVENUE CYCLE SOLUTIONS OFFERED BY KEY MARKET PLAYERS 115
TABLE 38 OTHER MID-REVENUE CYCLE SOLUTIONS MARKET, BY REGION,
2023–2030 (USD MILLION) 115
TABLE 39 BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 116
TABLE 40 BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY REGION,
2023–2030 (USD MILLION) 116
TABLE 41 CLAIMS PROCESSING SOLUTIONS OFFERED BY KEY MARKET PLAYERS 117
TABLE 42 CLAIMS PROCESSING SOLUTIONS MARKET, BY REGION,
2023–2030 (USD MILLION) 117
TABLE 43 DENIAL MANAGEMENT SOLUTIONS OFFERED BY KEY MARKET PLAYERS 118
TABLE 44 DENIAL MANAGEMENT SOLUTIONS MARKET, BY REGION,
2023–2030 (USD MILLION) 118
TABLE 45 OTHER BACK-END REVENUE CYCLE SOLUTIONS OFFERED
BY KEY MARKET PLAYERS 119
TABLE 46 OTHER BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY REGION,
2023–2030 (USD MILLION) 119
TABLE 47 REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 120
TABLE 48 REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 120
TABLE 49 PATIENT ACCESS OUTSOURCING SERVICES OFFERED BY KEY MARKET PLAYERS 121
TABLE 50 PATIENT ACCESS OUTSOURCING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 121
TABLE 51 MID-REVENUE CYCLE OUTSOURCING SERVICES OFFERED
BY KEY MARKET PLAYERS 122
TABLE 52 MID-REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 123
TABLE 53 BACK-END REVENUE CYCLE OUTSOURCING SERVICES OFFERED
BY KEY MARKET PLAYERS 123
TABLE 54 BACK-END REVENUE CYCLE OUTSOURCING SERVICES MARKET,
BY REGION, 2023–2030 (USD MILLION) 124
TABLE 55 REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE,
2023–2030 (USD MILLION) 126
TABLE 56 REVENUE CYCLE MANAGEMENT MARKET FOR ON-PREMISE SOLUTIONS,
BY REGION, 2023–2030 (USD MILLION) 127
TABLE 57 REVENUE CYCLE MANAGEMENT MARKET FOR CLOUD-BASED SOLUTIONS,
BY REGION, 2023–2030 (USD MILLION) 128
TABLE 58 REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 130
TABLE 59 REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 131
TABLE 60 REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS,
BY REGION, 2023–2030 (USD MILLION) 131
TABLE 61 REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 132
TABLE 62 REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES,
BY REGION, 2023–2030 (USD MILLION) 132
TABLE 63 REVENUE CYCLE MANAGEMENT MARKET FOR HOSPITALS, BY REGION,
2023–2030 (USD MILLION) 133
TABLE 64 REVENUE CYCLE MANAGEMENT MARKET FOR OTHER INPATIENT FACILITIES,
BY REGION, 2023–2030 (USD MILLION) 134
TABLE 65 REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 135
TABLE 66 REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES,
BY REGION, 2023–2030 (USD MILLION) 135
TABLE 67 REVENUE CYCLE MANAGEMENT MARKET FOR PHYSICIANS’ PRACTICES,
BY REGION, 2023–2030 (USD MILLION) 136
TABLE 68 REVENUE CYCLE MANAGEMENT MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2023–2030 (USD MILLION) 137
TABLE 69 REVENUE CYCLE MANAGEMENT MARKET FOR HOSPITAL OUTPATIENT FACILITIES, BY REGION, 2023–2030 (USD MILLION) 138
TABLE 70 REVENUE CYCLE MANAGEMENT MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2023–2030 (USD MILLION) 139
TABLE 71 REVENUE CYCLE MANAGEMENT MARKET FOR OTHER OUTPATIENT FACILITIES,
BY REGION, 2023–2030 (USD MILLION) 140
TABLE 72 REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PAYERS, BY REGION, 2023–2030 (USD MILLION) 141
TABLE 73 REVENUE CYCLE MANAGEMENT MARKET, BY REGION, 2023–2030 (USD MILLION) 143
TABLE 74 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 146
TABLE 75 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE, 2023–2030 (USD MILLION) 146
TABLE 76 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 146
TABLE 77 NORTH AMERICA: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 147
TABLE 78 NORTH AMERICA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 147
TABLE 79 NORTH AMERICA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 148
TABLE 80 NORTH AMERICA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 148
TABLE 81 NORTH AMERICA: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 149
TABLE 82 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2023–2030 (USD MILLION) 149
TABLE 83 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 150
TABLE 84 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 150
TABLE 85 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 150
TABLE 86 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 151
TABLE 87 US: KEY MACROINDICATORS 152
TABLE 88 US: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE,
2023–2030 (USD MILLION) 152
TABLE 89 US: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 153
TABLE 90 US: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 153
TABLE 91 US: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 154
TABLE 92 US: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 154
TABLE 93 US: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 155
TABLE 94 US: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 155
TABLE 95 US: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE,
2023–2030 (USD MILLION) 156
TABLE 96 US: REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 156
TABLE 97 US: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 156
TABLE 98 US: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 157
TABLE 99 US: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 157
TABLE 100 CANADA: KEY MACROINDICATORS 158
TABLE 101 CANADA: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE,
2023–2030 (USD MILLION) 158
TABLE 102 CANADA: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 159
TABLE 103 CANADA: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 159
TABLE 104 CANADA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 159
TABLE 105 CANADA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 160
TABLE 106 CANADA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 160
TABLE 107 CANADA: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 161
TABLE 108 CANADA: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE,
2023–2030 (USD MILLION) 161
TABLE 109 CANADA: REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 162
TABLE 110 CANADA: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 162
TABLE 111 CANADA: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 162
TABLE 112 CANADA: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 163
TABLE 113 EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 164
TABLE 114 EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE,
2023–2030 (USD MILLION) 165
TABLE 115 EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 165
TABLE 116 EUROPE: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 165
TABLE 117 EUROPE: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 166
TABLE 118 EUROPE: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 166
TABLE 119 EUROPE: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 167
TABLE 120 EUROPE: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 167
TABLE 121 EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE,
2023–2030 (USD MILLION) 168
TABLE 122 EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 168
TABLE 123 EUROPE: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 168
TABLE 124 EUROPE: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 169
TABLE 125 EUROPE: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 169
TABLE 126 GERMANY: KEY MACROINDICATORS 170
TABLE 127 GERMANY: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE,
2023–2030 (USD MILLION) 170
TABLE 128 GERMANY: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 171
TABLE 129 GERMANY: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 171
TABLE 130 GERMANY: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 171
TABLE 131 GERMANY: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 172
TABLE 132 GERMANY: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 172
TABLE 133 GERMANY: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 173
TABLE 134 GERMANY: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE,
2023–2030 (USD MILLION) 173
TABLE 135 GERMANY: REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 174
TABLE 136 GERMANY: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 174
TABLE 137 GERMANY: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 174
TABLE 138 GERMANY: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 175
TABLE 139 FRANCE: KEY MACROINDICATORS 176
TABLE 140 FRANCE: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE,
2023–2030 (USD MILLION) 176
TABLE 141 FRANCE: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 176
TABLE 142 FRANCE: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 177
TABLE 143 FRANCE: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 177
TABLE 144 FRANCE: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 178
TABLE 145 FRANCE: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 178
TABLE 146 FRANCE: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 179
TABLE 147 FRANCE: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE,
2023–2030 (USD MILLION) 179
TABLE 148 FRANCE: REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 180
TABLE 149 FRANCE: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 150 FRANCE: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 151 FRANCE: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 181
TABLE 152 UK: KEY MACROINDICATORS 182
TABLE 153 UK: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE,
2023–2030 (USD MILLION) 182
TABLE 154 UK: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 182
TABLE 155 UK: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 183
TABLE 156 UK: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 183
TABLE 157 UK: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 184
TABLE 158 UK: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 184
TABLE 159 UK: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 185
TABLE 160 UK: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE,
2023–2030 (USD MILLION) 185
TABLE 161 UK: REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 185
TABLE 162 UK: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 163 UK: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 164 UK: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 187
TABLE 165 ITALY: KEY MACROINDICATORS 188
TABLE 166 ITALY: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE,
2023–2030 (USD MILLION) 188
TABLE 167 ITALY: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 188
TABLE 168 ITALY: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 189
TABLE 169 ITALY: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 189
TABLE 170 ITALY: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 190
TABLE 171 ITALY: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 190
TABLE 172 ITALY: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 191
TABLE 173 ITALY: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE,
2023–2030 (USD MILLION) 191
TABLE 174 ITALY: REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 192
TABLE 175 ITALY: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 192
TABLE 176 ITALY: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 192
TABLE 177 ITALY: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 193
TABLE 178 SPAIN: KEY MACROINDICATORS 194
TABLE 179 SPAIN: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE,
2023–2030 (USD MILLION) 194
TABLE 180 SPAIN: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 194
TABLE 181 SPAIN: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 195
TABLE 182 SPAIN: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 195
TABLE 183 SPAIN: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 196
TABLE 184 SPAIN: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 196
TABLE 185 SPAIN: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 197
TABLE 186 SPAIN: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE,
2023–2030 (USD MILLION) 197
TABLE 187 SPAIN: REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 198
TABLE 188 SPAIN: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 198
TABLE 189 SPAIN: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 198
TABLE 190 SPAIN: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 199
TABLE 191 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE, 2023–2030 (USD MILLION) 200
TABLE 192 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 200
TABLE 193 REST OF EUROPE: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 200
TABLE 194 REST OF EUROPE: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 201
TABLE 195 REST OF EUROPE: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 201
TABLE 196 REST OF EUROPE: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 202
TABLE 197 REST OF EUROPE: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 202
TABLE 198 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2023–2030 (USD MILLION) 203
TABLE 199 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 203
TABLE 200 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 203
TABLE 201 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 204
TABLE 202 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 204
TABLE 203 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 207
TABLE 204 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE, 2023–2030 (USD MILLION) 207
TABLE 205 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 208
TABLE 206 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 208
TABLE 207 ASIA PACIFIC: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 209
TABLE 208 ASIA PACIFIC: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 209
TABLE 209 ASIA PACIFIC: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 210
TABLE 210 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 210
TABLE 211 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2023–2030 (USD MILLION) 211
TABLE 212 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 211
TABLE 213 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 211
TABLE 214 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 212
TABLE 215 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 212
TABLE 216 JAPAN: KEY MACROINDICATORS 213
TABLE 217 JAPAN: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE,
2023–2030 (USD MILLION) 213
TABLE 218 JAPAN: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 214
TABLE 219 JAPAN: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 214
TABLE 220 JAPAN: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 214
TABLE 221 JAPAN: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 215
TABLE 222 JAPAN: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 215
TABLE 223 JAPAN: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 216
TABLE 224 JAPAN: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE,
2023–2030 (USD MILLION) 216
TABLE 225 JAPAN: REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 217
TABLE 226 JAPAN: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 217
TABLE 227 JAPAN: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 217
TABLE 228 JAPAN: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 218
TABLE 229 CHINA: KEY MACROINDICATORS 219
TABLE 230 CHINA: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE,
2023–2030 (USD MILLION) 219
TABLE 231 CHINA: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 219
TABLE 232 CHINA: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 220
TABLE 233 CHINA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 220
TABLE 234 CHINA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 221
TABLE 235 CHINA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 221
TABLE 236 CHINA: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 222
TABLE 237 CHINA: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE,
2023–2030 (USD MILLION) 222
TABLE 238 CHINA: REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 223
TABLE 239 CHINA: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 223
TABLE 240 CHINA: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 223
TABLE 241 CHINA: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 224
TABLE 242 INDIA: KEY MACROINDICATORS 225
TABLE 243 INDIA: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE,
2023–2030 (USD MILLION) 225
TABLE 244 INDIA: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 225
TABLE 245 INDIA: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 226
TABLE 246 INDIA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 226
TABLE 247 INDIA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 227
TABLE 248 INDIA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 227
TABLE 249 INDIA: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 228
TABLE 250 INDIA: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE,
2023–2030 (USD MILLION) 228
TABLE 251 INDIA: REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 229
TABLE 252 INDIA: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 229
TABLE 253 INDIA: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 229
TABLE 254 INDIA: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 230
TABLE 255 REST OF ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE, 2023–2030 (USD MILLION) 231
TABLE 256 REST OF ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING, 2023–2030 (USD MILLION) 231
TABLE 257 REST OF ASIA PACIFIC: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 231
TABLE 258 REST OF ASIA PACIFIC: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 232
TABLE 259 REST OF ASIA PACIFIC: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 260 REST OF ASIA PACIFIC: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 233
TABLE 261 REST OF ASIA PACIFIC: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 233
TABLE 262 REST OF ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2023–2030 (USD MILLION) 234
TABLE 263 REST OF ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 234
TABLE 264 REST OF ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 234
TABLE 265 REST OF ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 235
TABLE 266 REST OF ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 235
TABLE 267 LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 236
TABLE 268 LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE, 2023–2030 (USD MILLION) 237
TABLE 269 LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 237
TABLE 270 LATIN AMERICA: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 237
TABLE 271 LATIN AMERICA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 238
TABLE 272 LATIN AMERICA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 238
TABLE 273 LATIN AMERICA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 239
TABLE 274 LATIN AMERICA: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 239
TABLE 275 LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2023–2030 (USD MILLION) 240
TABLE 276 LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 240
TABLE 277 LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 240
TABLE 278 LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 241
TABLE 279 LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 241
TABLE 280 BRAZIL: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE,
2023–2030 (USD MILLION) 242
TABLE 281 BRAZIL: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 242
TABLE 282 BRAZIL: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 243
TABLE 283 BRAZIL: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 243
TABLE 284 BRAZIL: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 244
TABLE 285 BRAZIL: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 244
TABLE 286 BRAZIL: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 245
TABLE 287 BRAZIL: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE,
2023–2030 (USD MILLION) 245
TABLE 288 BRAZIL: REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 246
TABLE 289 BRAZIL: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 246
TABLE 290 BRAZIL: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 246
TABLE 291 BRAZIL: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 247
TABLE 292 MEXICO: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE,
2023–2030 (USD MILLION) 248
TABLE 293 MEXICO: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 248
TABLE 294 MEXICO: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 248
TABLE 295 MEXICO: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 249
TABLE 296 MEXICO: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 249
TABLE 297 MEXICO: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 250
TABLE 298 MEXICO: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 250
TABLE 299 MEXICO: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE,
2023–2030 (USD MILLION) 251
TABLE 300 MEXICO: REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 251
TABLE 301 MEXICO: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 251
TABLE 302 MEXICO: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 252
TABLE 303 MEXICO: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES,
BY TYPE, 2023–2030 (USD MILLION) 252
TABLE 304 REST OF LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE, 2023–2030 (USD MILLION) 253
TABLE 305 REST OF LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING, 2023–2030 (USD MILLION) 253
TABLE 306 REST OF LATIN AMERICA: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 307 REST OF LATIN AMERICA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 254
TABLE 308 REST OF LATIN AMERICA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254
TABLE 309 REST OF LATIN AMERICA: BACK-END REVENUE CYCLE SOLUTIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 255
TABLE 310 REST OF LATIN AMERICA: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 255
TABLE 311 REST OF LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2023–2030 (USD MILLION) 256
TABLE 312 REST OF LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET,
BY END USER, 2023–2030 (USD MILLION) 256
TABLE 313 REST OF LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 256
TABLE 314 REST OF LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 257
TABLE 315 REST OF LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET
FOR OUTPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 257
TABLE 316 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET, BY REGION, 2023–2030 (USD MILLION) 259
TABLE 317 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE, 2023–2030 (USD MILLION) 259
TABLE 318 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING, 2023–2030 (USD MILLION) 259
TABLE 319 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 260
TABLE 320 MIDDLE EAST & AFRICA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 260
TABLE 321 MIDDLE EAST & AFRICA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 261
TABLE 322 MIDDLE EAST & AFRICA: BACK-END REVENUE CYCLE SOLUTIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 261
TABLE 323 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 262
TABLE 324 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2023–2030 (USD MILLION) 262
TABLE 325 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 263
TABLE 326 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 263
TABLE 327 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 263
TABLE 328 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 264
TABLE 329 GCC COUNTRIES: REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE, 2023–2030 (USD MILLION) 265
TABLE 330 GCC COUNTRIES: REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 265
TABLE 331 GCC COUNTRIES: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 265
TABLE 332 GCC COUNTRIES: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 266
TABLE 333 GCC COUNTRIES: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 266
TABLE 334 GCC COUNTRIES: BACK-END REVENUE CYCLE SOLUTIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 267
TABLE 335 GCC COUNTRIES: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 267
TABLE 336 GCC COUNTRIES: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2023–2030 (USD MILLION) 268
TABLE 337 GCC COUNTRIES: REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 268
TABLE 338 GCC COUNTRIES: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 268
TABLE 339 GCC COUNTRIES: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 269
TABLE 340 GCC COUNTRIES: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 269
TABLE 341 REST OF MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET,
BY SOLUTION TYPE, 2023–2030 (USD MILLION) 270
TABLE 342 REST OF MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET,
BY OFFERING, 2023–2030 (USD MILLION) 270
TABLE 343 REST OF MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 271
TABLE 344 REST OF MIDDLE EAST & AFRICA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 271
TABLE 345 REST OF MIDDLE EAST & AFRICA: MID-REVENUE CYCLE SOLUTIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 272
TABLE 346 REST OF MIDDLE EAST & AFRICA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 272
TABLE 347 REST OF MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT OUTSOURCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 273
TABLE 348 REST OF MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET,
BY DELIVERY MODE, 2023–2030 (USD MILLION) 273
TABLE 349 REST OF MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET,
BY END USER, 2023–2030 (USD MILLION) 274
TABLE 350 REST OF MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 274
TABLE 351 REST OF MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 274
TABLE 352 REST OF MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2023–2030 (USD MILLION) 275
TABLE 353 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN REVENUE CYCLE MANAGEMENT MARKET, JANUARY 2022–MAY 2025 276
TABLE 354 REVENUE CYCLE MANAGEMENT MARKET: DEGREE OF COMPETITION 280
TABLE 355 REVENUE CYCLE MANAGEMENT MARKET: REGION FOOTPRINT 287
TABLE 356 REVENUE CYCLE MANAGEMENT MARKET: SOLUTION TYPE FOOTPRINT 288
TABLE 357 REVENUE CYCLE MANAGEMENT MARKET: OFFERING FOOTPRINT 289
TABLE 358 REVENUE CYCLE MANAGEMENT MARKET: END-USER FOOTPRINT 290
TABLE 359 REVENUE CYCLE MANAGEMENT MARKET: DETAILED LIST OF
KEY STARTUP/SME PLAYERS 293
TABLE 360 REVENUE CYCLE MANAGEMENT MARKET: COMPETITIVE BENCHMARKING OF SMES/STARTUPS, BY REGION 293
TABLE 361 REVENUE CYCLE MANAGEMENT MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 296
TABLE 362 REVENUE CYCLE MANAGEMENT MARKET: DEALS, JANUARY 2022–MAY 2025 297
TABLE 363 REVENUE CYCLE MANAGEMENT MARKET: EXPANSIONS,
JANUARY 2022–MAY 2025 297
TABLE 364 REVENUE CYCLE MANAGEMENT MARKET: OTHER DEVELOPMENTS,
JANUARY 2022–MAY 2025 298
TABLE 365 OPTUM, INC.: COMPANY OVERVIEW 299
TABLE 366 OPTUM, INC.: PRODUCTS & SERVICES OFFERED 300
TABLE 367 OPTUM, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–MAY 2025 301
TABLE 368 OPTUM, INC.: DEALS, JANUARY 2022–MAY 2025 301
TABLE 369 ORACLE: COMPANY OVERVIEW 304
TABLE 370 ORACLE: PRODUCTS & SERVICES OFFERED 305
TABLE 371 ORACLE: PRODUCT/SERVICE LAUNCHES & UPGRADES, JANUARY 2022–MAY 2025 307
TABLE 372 ORACLE: DEALS, JANUARY 2022–MAY 2025 308
TABLE 373 MCKESSON CORPORATION: COMPANY OVERVIEW 310
TABLE 374 MCKESSON CORPORATION: PRODUCTS & SERVICES OFFERED 311
TABLE 375 MCKESSON CORPORATION: DEALS, JANUARY 2022–MAY 2025 312
TABLE 376 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 314
TABLE 377 EPIC SYSTEMS CORPORATION: PRODUCTS & SERVICES OFFERED 314
TABLE 378 EPIC SYSTEMS CORPORATION: PRODUCT/SERVICE LAUNCHES & UPGRADES, JANUARY 2022–MAY 2025 315
TABLE 379 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2022–MAY 2025 315
TABLE 380 SOLVENTUM: COMPANY OVERVIEW 317
TABLE 381 SOLVENTUM: PRODUCTS & SERVICES OFFERED 319
TABLE 382 SOLVENTUM: DEALS, JANUARY 2022–MAY 2025 319
TABLE 383 R1 RCM INC.: COMPANY OVERVIEW 321
TABLE 384 R1 RCM INC.: PRODUCTS & SERVICES OFFERED 321
TABLE 385 R1 RCM INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–MAY 2025 323
TABLE 386 R1 RCM INC.: DEALS, JANUARY 2022–MAY 2025 324
TABLE 387 R1 RCM INC.: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 325
TABLE 388 EXPERIAN INFORMATION SOLUTIONS, INC.: COMPANY OVERVIEW 326
TABLE 389 EXPERIAN INFORMATION SOLUTIONS, INC.: PRODUCTS & SERVICES OFFERED 327
TABLE 390 EXPERIAN INFORMATION SOLUTIONS, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–MAY 2025 329
TABLE 391 EXPERIAN INFORMATION SOLUTIONS, INC.: DEALS, JANUARY 2022–MAY 2025 329
TABLE 392 CONIFER HEALTH SOLUTIONS: COMPANY OVERVIEW 330
TABLE 393 CONIFER HEALTH SOLUTIONS: PRODUCTS & SERVICES OFFERED 330
TABLE 394 CONIFER HEALTH SOLUTIONS: DEALS, JANUARY 2022–MAY 2025 331
TABLE 395 VERADIGM LLC: COMPANY OVERVIEW 332
TABLE 396 VERADIGM LLC: PRODUCTS & SERVICES OFFERED 333
TABLE 397 VERADIGM LLC: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–MAY 2025 334
TABLE 398 VERADIGM LLC: DEALS, JANUARY 2022–MAY 2025 335
TABLE 399 ECLINICALWORKS: COMPANY OVERVIEW 336
TABLE 400 ECLINICALWORKS: PRODUCTS & SERVICES OFFERED 336
TABLE 401 ECLINICALWORKS: DEALS, JANUARY 2021–FEBRUARY 2025 337
TABLE 402 COGNIZANT: COMPANY OVERVIEW 338
TABLE 403 COGNIZANT: PRODUCTS & SERVICES OFFERED 339
TABLE 404 COGNIZANT: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–MAY 2025 340
TABLE 405 COGNIZANT: DEALS, JANUARY 2022–MAY 2025 341
TABLE 406 ATHENAHEALTH, INC.: COMPANY OVERVIEW 342
TABLE 407 ATHENAHEALTH, INC.: PRODUCTS & SERVICES OFFERED 342
TABLE 408 ATHENAHEALTH, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 343
TABLE 409 ATHENAHEALTH, INC.: DEALS, JANUARY 2022–MAY 2025 344
TABLE 410 ATHENAHEALTH, INC.: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 345
TABLE 411 THE SSI GROUP, LLC: COMPANY OVERVIEW 346
TABLE 412 THE SSI GROUP, LLC: PRODUCTS & SERVICES OFFERED 346
TABLE 413 THE SSI GROUP, LLC: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–MAY 2025 347
TABLE 414 HURON CONSULTING GROUP INC.: COMPANY OVERVIEW 348
TABLE 415 HURON CONSULTING GROUP INC.: PRODUCTS & SERVICES OFFERED 349
TABLE 416 ADVANCEDMD, INC.: COMPANY OVERVIEW 350
TABLE 417 ADVANCEDMD, INC.: PRODUCTS & SERVICES OFFERED 350
TABLE 418 ADVANCEDMD, INC.: PRODUCT/SERVICE UPGRADES, JANUARY 2022–MAY 2025 351
TABLE 419 ADVANCEDMD, INC.: DEALS, JANUARY 2022–MAY 2025 352
TABLE 420 GEBBS: COMPANY OVERVIEW 353
TABLE 421 GEBBS: PRODUCTS & SERVICES OFFERED 353
TABLE 422 GEBBS: DEALS, JANUARY 2022–MAY 2025 354
TABLE 423 TRUBRIDGE: COMPANY OVERVIEW 356
TABLE 424 TRUBRIDGE: PRODUCTS & SERVICES OFFERED 357
TABLE 425 TRUBRIDGE: DEALS, JANUARY 2022–MAY 2025 358
TABLE 426 CARECLOUD, INC.: COMPANY OVERVIEW 359
TABLE 427 CARECLOUD, INC.: PRODUCTS & SERVICES OFFERED 360
TABLE 428 CARECLOUD, INC.: DEALS, JANUARY 2022–MAY 2025 361
TABLE 429 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY OVERVIEW 362
TABLE 430 MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCTS & SERVICES OFFERED 362
TABLE 431 MEDICAL INFORMATION TECHNOLOGY, INC.: DEALS, JANUARY 2022–MAY 2025 363
TABLE 432 MEDHOST: COMPANY OVERVIEW 364
TABLE 433 MEDHOST: PRODUCTS & SERVICES OFFERED 364
TABLE 434 MEDHOST: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 365
TABLE 435 MEDHOST: DEALS, JANUARY 2022–MAY 2025 366
TABLE 436 MEDHOST.: EXPANSIONS, JANUARY 2021–FEBRUARY 2025 366
LIST OF FIGURES
FIGURE 1 REVENUE CYCLE MANAGEMENT MARKET SEGMENTATION & REGIONAL SCOPE 36
FIGURE 2 REGIONAL SNAPSHOT 37
FIGURE 3 RESEARCH DESIGN 41
FIGURE 4 PRIMARY SOURCES 43
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 45
FIGURE 6 MARKET SIZE ESTIMATION 46
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 48
FIGURE 8 CAGR PROJECTIONS: OVERALL REVENUE CYCLE MANAGEMENT MARKET 48
FIGURE 9 DATA TRIANGULATION METHODOLOGY 50
FIGURE 10 REVENUE CYCLE MANAGEMENT MARKET, BY SOLUTION TYPE,
2025 VS. 2030 (USD MILLION) 53
FIGURE 11 REVENUE CYCLE MANAGEMENT MARKET, BY OFFERING,
2025 VS. 2030 (USD MILLION) 54
FIGURE 12 REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE,
2025 VS. 2030 (USD MILLION) 55
FIGURE 13 REVENUE CYCLE MANAGEMENT MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 55
FIGURE 14 REVENUE CYCLE MANAGEMENT MARKET: GEOGRAPHIC SNAPSHOT 56
FIGURE 15 GROWING REGULATORY REQUIREMENTS AND GOVERNMENT
INITIATIVES TO DRIVE MARKET 58
FIGURE 16 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 59
FIGURE 17 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 60
FIGURE 18 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH
DURING FORECAST PERIOD 61
FIGURE 19 REVENUE CYCLE MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 62
FIGURE 20 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009–2024 69
FIGURE 21 MEDIAN HEALTHCARE DATA BREACH SIZE BY YEAR IN US, 2009–2024 70
FIGURE 22 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009–2023 70
FIGURE 23 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73
FIGURE 24 REVENUE CYCLE MANAGEMENT MARKET: ECOSYSTEM ANALYSIS 77
FIGURE 25 REVENUE CYCLE MANAGEMENT MARKET: VALUE CHAIN ANALYSIS 79
FIGURE 26 REVENUE CYCLE MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 80
FIGURE 27 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR REVENUE CYCLE MANAGEMENT PATENTS (JANUARY 2015–MAY 2025) 86
FIGURE 28 MAJOR PATENTS IN REVENUE CYCLE MANAGEMENT MARKET
(JANUARY 2015–MAY 2025) 87
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 90
FIGURE 30 KEY BUYING CRITERIA FOR REVENUE CYCLE MANAGEMENT COMPONENTS 91
FIGURE 31 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET SNAPSHOT 145
FIGURE 32 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET SNAPSHOT 206
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN REVENUE CYCLE MANAGEMENT MARKET, 2020–2024 279
FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS IN REVENUE CYCLE MANAGEMENT MARKET, 2024 280
FIGURE 35 REVENUE CYCLE MANAGEMENT: KEY PLAYERS, 2024 283
FIGURE 36 REVENUE CYCLE MANAGEMENT MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 285
FIGURE 37 REVENUE CYCLE MANAGEMENT MARKET: COMPANY FOOTPRINT 286
FIGURE 38 REVENUE CYCLE MANAGEMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 292
FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS, 2025 294
FIGURE 40 EV/EBITDA OF KEY VENDORS, 2025 294
FIGURE 41 REVENUE CYCLE MANAGEMENT MARKET: BRAND/SOFTWARE COMPARISON 295
FIGURE 42 OPTUM, INC.: COMPANY SNAPSHOT (2024) 300
FIGURE 43 ORACLE: COMPANY SNAPSHOT (2023) 305
FIGURE 44 MCKESSON CORPORATION: COMPANY SNAPSHOT (2024) 310
FIGURE 45 SOLVENTUM: COMPANY SNAPSHOT (2024) 318
FIGURE 46 EXPERIAN INFORMATION SOLUTIONS, INC.: COMPANY SNAPSHOT (2023) 327
FIGURE 47 VERADIGM LLC: COMPANY SNAPSHOT (2022) 333
FIGURE 48 COGNIZANT: COMPANY SNAPSHOT (2024) 339
FIGURE 49 HURON CONSULTING GROUP INC.: COMPANY SNAPSHOT (2024) 348
FIGURE 50 TRUBRIDGE: COMPANY SNAPSHOT (2024) 357
FIGURE 51 CARECLOUD, INC.: COMPANY SNAPSHOT (2024) 359
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11